TITAN PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Titan Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2024.
  • Titan Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $32K, a 79.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $32K -$122K -79.2% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $63K -$120K -65.6% Dec 31, 2023 10-Q 2024-08-15
Q3 2023 $94K -$118K -55.7% Sep 30, 2023 10-K 2024-04-01
Q2 2023 $124K -$117K -48.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $154K -$115K -42.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $183K -$114K -38.4% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $212K -$112K -34.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $241K -$112K -31.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $269K +$197K +274% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $297K +$156K +111% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $324K +$116K +55.8% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $353K +$80K +29.3% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $72K -$264K -78.6% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $141K -$256K -64.5% Dec 31, 2020 10-K 2022-03-25
Q3 2020 $208K -$248K -54.4% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $273K -$241K -46.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $336K -$233K -40.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $397K +$397K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $456K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $514K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $569K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.